Coronary Stent Market Research Report ‚Äď Forecast to 2030

Coronary Stent Market Research Report: By Type (Bare-Metal Stents, Drug-Eluting Stents, and Bio Absorbable Stents), by Mode of Delivery (Balloon-Expandable Stents and Self-Expanding Stents), by End-User (Hospitals & Clinics) -Forecast Till 2030

ID: MRFR/MED/4459-HCR | | Region: Global | 100 Pages         

Coronary Stent Market Speak to Analyst Request a Free Sample

Coronary Stent Market Overview:


The Coronary Stent Market is anticipated to reach USD 9,113.14 Million by 2030 at 3.20% CAGR during the forecast period 2022-2030.


The market for coronary stents is growing due to several causes, including an increase in the frequency of coronary artery disorders, better patient outcomes from stenting, and the emergence of new trends in coronary artery stents. The market's expansion is hampered by the high cost of treatments related to coronary stents and the availability of alternatives for treating coronary artery disorders. For the Coronary Stents Market Forecast term, it is anticipated that rising demand for coronary stents in emerging nations and increased knowledge of acceptable insurance & reimbursement policies would present attractive growth prospects.


The market for coronary stents is mainly driven by the rising demand for minimally invasive surgical procedures. With the use of a minimally invasive surgical approach, there has been a decrease in post-operative trauma and problems, which is the primary growth driver. Other benefits of using sophisticated and miniature coronary stents include shorter hospital stays and quicker recovery.


New and improved drug-eluting stents are now generally regarded as safe and effective when used in conjunction with anti-clotting medication as directed. Drug-eluting stents are often less likely to result in restenosis than bare-metal stents. A drug-eluting stent is the most typical stent used to treat a blockage of the cardiac arteries. Many patients with cardiac conditions have been effectively treated using drug-eluting stents, obviating the need for more invasive operations like coronary artery bypass surgery. Drug-eluting stents' benefits and rising popularity are projected to fuel market expansion throughout the projection period.


COVID 19 Analysis


The outbreak of Covid-19 has affected many industries and markets to a great extent. Among all others, the Coronary Stent Market is most effective due to this pandemic situation. Reducing back of the creation of blood vessel stents is expected, inferable from the spread of the COVID-19 pandemic. Increasing contamination rates have moved the need towards tending to patients with COVID-19. This has consigned non-crisis techniques to the patio, making an accumulation of cardiovascular patients. In any case, heart inconveniences emerging because of the COVID-19 disease, for example, arrhythmia and tachycardia, will be given first concern.


Market Dynamics


Major Drivers of the Market


An increase in the occurrence of CAD and fast reception of coronary stents for the treatment is considered the major driver of the market that is helping develop the Coronary Stent Market to a great extent. Notwithstanding, because of low gross pay in nations like Latin America, there are fewer uses on advancing new techniques and gadgets for the treatment of CAD. The absences of medical care offices and expanded requirements for therapy gadgets for CAD have expanded the infiltration of significant parts in the Middle East district. The Market development is driven by enhancements in the medical services framework and ascends in extra cash.



  • Significant Opportunities For The Market


The major opportunities in the Coronary Stent Market are Bioresorbable Vascular Scaffolds and Emerging Markets. These opportunities play an important role in enhancing the growth of the Market for the estimated period. 


The advancement of a bioresorbable vascular framework (BVS) and extension in developing business sectors give huge development opportunities in the Coronary Stent Market critical development openings on the lookout. Nonetheless, elective treatment strategies for CAD, tough guidelines for item endorsement, and various instances of item disappointment and item review might obstruct the development of this Market during the estimated time frame.



  • Market Restraints


Accessibility of Alternative Treatment Methods for Coronary Artery Disease, Stringent Regulations for Product Approval and Product Failure and Product Recalls is the limiting variable on the lookout in the Coronary Stent Market. 


Elective treatment techniques for CAD and item disappointment and item reviews are a portion of the elements that might impede the general development of the Coronary Stent Market. As coronary stents are grouped under the Class III classification (great danger) of clinical gadgets, the guidelines for their endorsement are incredibly tough. This confines that the quantity of item dispatched in this fragment, influences the Market development.



  • Cumulative Growth Analysis


There has likewise been an appeal for negligibly obtrusive surgeries, which altogether drives the Coronary Stent Market to a great extent. Hence, there has been a decrease in post-employable injury and intricacies with utilizing an insignificantly invasive surgery, which is the significant development driver. Decreased clinic stays and lesser mending-time are different benefits related to the utilization of cutting-edge and scaled-down coronary stents in the Market.


Segment Overview


The worldwide Coronary Stent Market is segmented on type, method of conveyance, material, and end-client. 



  • By Type


Based on type, the Coronary Stent Market is fragmented into uncovered metal stents, drug-eluting stents, and bioabsorbable stents. 



  • By delivery method


The Coronary Stent Market is segmented into swell expandable stents and self-growing stents based on the delivery method. 



  • By Material


Based on material, the Coronary Stent Market is sectioned into metallic stents, cobalt-chromium, platinum chromium, nickel-titanium, tempered steel, and others. 



  • By end-user


The Coronary Stent Market is sectioned into medical clinics and facilities, cardiovascular focuses, careful mobile focuses, and others based on end-client.


Regional Analysis


The American Coronary Stent Market Outlook is divided into two locales, North America and South America. As the biggest market, North America is predominantly determined by the expanding patient populace experiencing coronary illness, developing interest in medical services, and expanding geriatric populace. Besides, the U.S. is the biggest market in North America, attributable to the presence of an enormous number of market players fabricating coronary stents and the expanding mindfulness about hazard factors for coronary illness. Canada is relied upon to be the quickest developing business sector driven by the by and large expanding interest for clinical gadgets with progress in coronary stent gadgets. South America is relied upon to be the quickest developing business sector because of innovative gadgets for finding and the expanding interest for treatment choices of coronary illness.


Competitive Landscape


The major key players of the Coronary Stent Market are mentioned below:-



  • BIOTRONIK SE & Co. KG (Germany)

  • Reva Medical Inc. (U.S.)

  • MicroPort Scientific Corporation (China)

  • B. Braun Melsungen AG (Germany)

  • Transluminal GmbH (Germany)

  • Biosensors International Group, Ltd. (Singapore)

  • Terumo Corporation (Japan)

  • Medtronic plc (Ireland)

  • Boston Scientific Corporation (U.S.)

  • Elixir Medical Corporation (U.S.)

  • Merril Life Sciences Pvt. Ltd. (India)

  • Vascular Concepts (India)

  • Abbott Laboratories (U.S.)

  • STENTS SA (France)

  • Kyoto Medical Planning Co. Ltd. (Japan)


Recent Developments


Due to the dominance of the leading businesses operating in the international market, North America accounts for the most significant market share for coronary stents. In addition, the region is seeing an ageing population, a rise in the frequency of cardiac disease, and technological improvements. The market for coronary stents in North America has also been driven by other reasons, such as a favourable reimbursement environment.


Report Overview


The Global Coronary Stent Market or overviews are as follows:



  • Global Market Share¬†Overview

  • COVID 19 impact on Global Market

  • Market¬†dynamics

  • Market Value¬†chain analysis¬†

  • Market Overview

  • Regional Analysis as per the Market Forecast

  • Market Competitive Landscape

  • Market Trends¬†Developments


This report highlights the growth aspects of the global Coronary Stent Market Growth Analysis. Along with that, this report also intends to put up the competitive landscape and recent developments on the table to explain this global Market Analysis.



Report Scope:

Report Attribute/Metric Details
  Market Size   9,113.14 Million
  CAGR   3.20%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Mode of delivery, Material, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Medtronic plc (Ireland), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.),STENTYS SA (France), Biosensors International Group, Ltd. (Singapore), Kyoto Medical Planning Co. Ltd. (Japan), Elixir Medical Corporation (U.S.), and Reva Medical Inc. (U.S.)
  Key Market Opportunities   Favorable reimbursement policies
  Key Market Drivers

  • High prevalence of heart-related diseases
  • Huge demand for diagnosis and treatment methods


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Coronary stents are small stretchy tube-like devices used to expand the arteries of the patient in order to prevent blockage.

    The Coronary Stent Market is expected to exhibit a strong 3.20% CAGR over the forecast period from 2022 to 2030.

    Growing prevalence of heart-related diseases is the major driver for the coronary stent market.

    Americas hold a dominant share in the global market.

    Leading players in the Coronary Stent Market include B. Braun Melsungen, Terumo, and Medtronic, among others.